Janice Drew Selected Research

Herpesviridae Infections (Herpesvirus Infection)

1/2020

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janice Drew Research Topics

Disease

6	Hyperhidrosis 01/2021 - 01/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2018 - 08/2018
1	Conjunctivitis 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Herpesviridae Infections (Herpesvirus Infection) 01/2020
1	Pruritus (Itching) 01/2020
1	Injection Site Reaction 01/2020
1	Obesity 08/2011
1	Neoplasms (Cancer) 03/2003

Drug/Important Bio-Agent (IBA)

6	glycopyrronium tosylateIBA 01/2021 - 01/2019
5	Cholinergic Antagonists (Anticholinergics)IBA 01/2021 - 01/2019
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 08/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2018 - 08/2018
2	Certolizumab Pegol FDA Link 08/2018 - 08/2018
1	Interleukin-13IBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	lebrikizumabIBA 01/2020
1	Etanercept (Enbrel)FDA Link 08/2018
1	DNA (Deoxyribonucleic Acid)IBA 03/2003
1	AntioxidantsIBA 03/2003

Therapy/Procedure

1	Plant-Based Diet 08/2011